| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5656903 | Nutrition | 2017 | 36 Pages |
Abstract
Ï-3 PUFAs may have a therapeutic role in decreasing pain associated with RA, with doses of 3 to 6Â g/d appearing to have a greater effect. Due to the limitations identified in the RCTs included in this review, more research is needed to investigate Ï-3 PUFAs in larger populations and over extended periods of time.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Mozghan Abdulrazaq, Jacqueline K. M.Sc., Philip C. Ph.D., D.Phil.,